Company intelligence / Profile preview

Bio-PRF

Jupiter, Florida, United Statesbio-prf.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bio‑PRF has pioneered the first commercially available horizontal centrifuge system for producing platelet rich fibrin (PRF), enabling significantly higher concentrations of platelets and leukocytes compared to traditional fixed-angle systems. Their protocols are supported by preclinical and clinical data published in peer-reviewed journals. The company also offers adjunct technologies such as the Bio‑Heat heating system to extend PRF working properties[1][2][4][6].

Therapeutic areas: OtherDermatology
Modalities: DeviceAutologous biologic (platelet rich fibrin, PRF)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Bio-PRF.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-PRF.

Explore the full profile